Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

NCT00016224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: thalidomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]